Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About HIT Interactive Breakdown Better Bets vs. HIT Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Health In Tech (HIT)

Market Price (10/31/2025): $2.6 | Market Cap: $144.0 Mil
Sector: Information Technology | Industry: Application Software

Health In Tech (HIT)

Market Price (10/31/2025): $2.6
Market Cap: $144.0 Mil
Sector: Information Technology
Industry: Application Software

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 30%		  Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 73x, P/EPrice/Earnings or Price/(Net Income) is 106x
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 13%		  Stock price has recently run up significantly
6M Rtn6 month market price return is 329%
2 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -85%		  Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.6%
0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 30%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 13%
2 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -85%
3 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 73x, P/EPrice/Earnings or Price/(Net Income) is 106x
4 Stock price has recently run up significantly
6M Rtn6 month market price return is 329%
5 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.6%

Market Valuation & Key Metrics

HITS&P 500
REVENUE GROWTHVERY GOOD
Rev LTM ($ Bil)0.0
Rev Chg Q86.2%6.4%
Rev Chg LTM29.7%5.4%
Rev Chg 3Y Avg29.7%5.3%
PROFITABILITYPOOR
Op Inc LTM ($ Bil)0.0
CFO LTM ($ Bil)0.0
Net Inc LTM ($ Bil)0.0
Op Mgn LTM5.0%18.7%
CFO/Rev LTM13.5%20.4%
Net Inc Mgn5.1%12.8%
VALUATIONHIGH
P/S5.43.2
P/CFO40.015.5
P/FCF109.820.6
P/E105.823.6
STABILITYVERY GOOD
Debt/Equity0.000.21
Cash/Assets0.370.07

HIT Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
The 328.6% change in HIT stock from 5/1/2025 to 10/30/2025 was primarily driven by a 159.0% change in the company's P/E Multiple.

501202510302025Change
Stock Price ($)0.612.61328.57%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)19.4926.6936.95%
Net Income Margin (%)3.44%5.10%48.24%
P/E Multiple41.01106.19158.95%
Shares Outstanding (Mil)45.1555.38-22.67%
Cumulative Contribution306.56%

LTM = Last Twelve Months as of date shown
null

null
null

null

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
HIT Return------51%-45%
Peers Return20%8%-11%22%57%-16%85%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
HIT Win Rate---- 78% 
Peers Win Rate27%22%12%35%40%42% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
HIT Max Drawdown------90% 
Peers Max Drawdown-16%-4%-14%-2%-6%-25% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: ADSK, MANH, BIYA, BLIV, BMR.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

HIT has limited trading history. Below is the Information Technology sector ETF (XLK) in its place.

Unique KeyEventXLKS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-34.0%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven51.6%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven278 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-31.5%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven46.0%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven79 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-24.1%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven31.8%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven105 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-53.6%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven115.3%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven1183 days1480 days

Compare to


In The Past

SPDR Select Sector Fund's stock fell -34.0% during the 2022 Inflation Shock from a high on 12/27/2021. A -34.0% loss requires a 51.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Health In Tech (HIT)

Better Bets than Health In Tech (HIT)

 HITBetter Performance than HIT
MetricValueIndustry (Application Software)
Rev Chg LTM29.7%PLTR (38.8%), MNDY (30.2%), LIF (30.0%), SOUN (137.0%), CWAN (36.7%)
Op Mgn LTM5.0%ORCL (31.6%), PLTR (16.6%), SAP (26.4%), CRM (21.2%), SHOP (15.3%)
CFO/Rev LTM13.5%ORCL (36.5%), PLTR (50.3%), SAP (20.0%), CRM (33.3%), SHOP (18.3%)
FCF/Rev LTM4.9%PLTR (49.7%), SAP (17.7%), CRM (31.6%), SHOP (18.1%), INTU (32.3%)
Total Yield0.9%ORCL (2.4%), SAP (2.3%), CRM (3.2%), SHOP (1.0%), INTU (2.8%)
 HITBetter Performance than HIT
MetricValueAll Other Sectors
Rev Chg LTM29.7%LLY (36.8%), APP (48.2%), HOOD (59.6%), WELL (32.6%), MELI (35.8%)
Op Mgn LTM5.0%GOOGL (32.2%), AMZN (11.4%), META (43.2%), TSLA (5.1%), LLY (43.0%)
CFO/Rev LTM13.5%GOOGL (39.3%), AMZN (18.1%), META (56.8%), TSLA (16.5%), LLY (20.5%)
FCF/Rev LTM4.9%GOOGL (19.1%), META (23.7%), TSLA (7.1%), V (56.8%), MA (49.2%)
Total Yield0.9%GOOGL (3.9%), AMZN (3.0%), META (3.8%), JPM (6.6%), WMT (3.5%)
 Best Bets In Information Technology Sector
 HITVRSN NVDA RMBS QLYS ADBE YOU GEN IDCC DBX KLAC
What You Pay           
P/E106.227.157.150.724.320.616.527.022.216.139.5
P/EBIT73.119.649.043.222.716.519.69.917.713.732.4
What You Get           
Rev Chg Q86.2%7.3%55.6%22.7%10.3%10.7%17.5%30.3%34.5%-1.4%23.6%
Rev Chg LTM29.7%5.5%71.6%31.0%9.6%10.7%19.8%10.6%21.8%-0.0%23.9%
Rev Chg 3Y Avg�5.2%92.0%17.3%12.5%10.5%35.5%14.8%23.3%4.1%10.4%
FCF/Rev 3Y Avg�57.4%41.3%39.3%39.0%37.7%37.3%35.9%35.1%32.9%31.1%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 24%, alpha of 2.9%, and sharpe of 1.04

Latest Trefis Analyses

TitleTopic
0DASHBOARDS 
1Health In Tech Stock Lost 18%, Buy Or Wait?Return

Trade Ideas

Select past ideas related to HIT. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADBE_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025ADBEAdobeMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-4.2%-4.2%-6.7%
CRM_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025CRMSalesforceMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		6.1%6.1%-0.6%
MPWR_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025MPWRMonolithic Power SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		18.8%18.8%-1.8%
POWI_9262025_Dip_Buyer_High_CFO_Margins_ExInd_DE09262025POWIPower IntegrationsDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap		3.7%3.7%-13.4%
ROP_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025ROPRoper TechnologiesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-10.5%-10.5%-10.5%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADBE_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025ADBEAdobeMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-4.2%-4.2%-6.7%
CRM_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025CRMSalesforceMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		6.1%6.1%-0.6%
MPWR_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025MPWRMonolithic Power SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		18.8%18.8%-1.8%
POWI_9262025_Dip_Buyer_High_CFO_Margins_ExInd_DE09262025POWIPower IntegrationsDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap		3.7%3.7%-13.4%
ROP_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025ROPRoper TechnologiesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-10.5%-10.5%-10.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Health In Tech

Financials

HITADSKMANHBIYABLIVBMRMedian
NameHealth I.Autodesk Manhatta.Baiya In.BeLive Beamr Im. 
Mkt Price2.61300.77179.870.303.602.593.10
Mkt Cap0.164.110.9---10.9
Rev LTM276,6051,067---1,067
Op Inc LTM11,515276---276
FCF LTM11,847333---333
FCF 3Y Avg-1,704271---987
CFO LTM41,925347---347
CFO 3Y Avg-1,775280---1,027

Growth & Margins

HITADSKMANHBIYABLIVBMRMedian
NameHealth I.Autodesk Manhatta.Baiya In.BeLive Beamr Im. 
Rev Chg LTM29.7%13.8%4.1%---13.8%
Rev Chg 3Y Avg-11.7%13.1%---12.4%
Rev Chg Q86.2%17.1%3.4%---17.1%
QoQ Delta Rev Chg LTM19.3%4.1%0.9%---4.1%
Op Mgn LTM5.0%22.9%25.9%---22.9%
Op Mgn 3Y Avg-21.5%24.4%---23.0%
QoQ Delta Op Mgn LTM-0.1%0.8%-0.2%----0.1%
CFO/Rev LTM13.5%29.1%32.5%---29.1%
CFO/Rev 3Y Avg-30.7%27.9%---29.3%
FCF/Rev LTM4.9%28.0%31.2%---28.0%
FCF/Rev 3Y Avg-29.5%27.0%---28.3%

Valuation

HITADSKMANHBIYABLIVBMRMedian
NameHealth I.Autodesk Manhatta.Baiya In.BeLive Beamr Im. 
Mkt Cap0.164.110.9---10.9
P/S5.49.710.2---9.7
P/EBIT73.145.339.3---45.3
P/E106.261.450.3---61.4
P/CFO40.233.331.3---33.3
Total Yield0.9%1.6%2.0%---1.6%
Dividend Yield0.0%0.0%0.0%---0.0%
FCF Yield 3Y Avg-3.3%2.0%---2.6%
D/E0.00.00.0---0.0
Net D/E-0.10.0-0.0----0.0

Returns

HITADSKMANHBIYABLIVBMRMedian
NameHealth I.Autodesk Manhatta.Baiya In.BeLive Beamr Im. 
1M Rtn-18.7%-5.3%-12.2%-48.0%-1.1%-15.4%-13.8%
3M Rtn26.1%-0.8%-18.1%-56.5%36.4%-14.8%-7.8%
6M Rtn328.6%10.0%0.7%-93.3%-18.0%5.3%3.0%
12M Rtn-4.1%-32.3%---20.2%-20.2%
3Y Rtn-40.3%47.8%---44.1%
1M Excs Rtn-21.8%-6.4%-11.5%-50.8%-4.9%-16.7%-14.1%
3M Excs Rtn21.1%-8.1%-25.6%-65.8%43.8%-23.6%-15.9%
6M Excs Rtn306.8%-11.8%-21.0%-115.1%-39.7%-16.5%-18.7%
12M Excs Rtn--12.2%-51.8%---41.0%-41.0%
3Y Excs Rtn--37.4%-42.1%----39.8%

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q1
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/2023
Filing Date8/8/20255/9/20253/17/202512/23/20248/30/20246/27/202412/23/202412/23/20248/30/20246/27/2024
Key Financials Quarterly          
Total Revenue9854555554
Ebitda1101102101
Operating Income10-00101101
Net Income10-00001001
EPS0.010.01-0.000.010.010.000.020.010.010.01
Key Financials TTM          
Total Revenue TTM27221920212019---
Ebitda TTM3224334---
Operating Income TTM1113333---
Net Income TTM1112222---
Growth Rates Quarterly          
Total Revenue Growth86.2%56.4%-6.0%-14.9%10.2%23.3%----
EBITDA Growth38.3%66.9%-98.4%7.6%67.6%-54.3%----
Operating Income Growth35.5%44.6%-121.7%-15.3%59.7%-69.1%----
Net Income Growth86.6%395.9%-114.4%-6.5%16.0%-87.1%----
Margins Quarterly          
EBITDA Margin10.4%10.2%0.5%15.9%14.0%9.6%30.9%12.5%9.2%25.8%
Operating Income Margin7.8%6.0%-6.4%9.8%10.7%6.5%27.9%9.9%7.4%25.8%
Net Income Margin6.8%6.2%-2.9%8.4%6.8%2.0%19.2%7.7%6.4%18.8%
Cash & Debt          
Total Cash8882212---
Total Debt0000222000
Net Debt / (Cash)-8-7-8-201-1---
Cash Flows Quarterly          
FCF from Operations11-121-1-0110
Cash Flows TTM          
FCF from Operations TTM4322102---
Returns to Shareholders Quarterly          
Dividends0000000000
Share Repurchases-0-0-0-0-0-0-0-0-0-0
Return on Invested Capital (ROIC) Quarterly          
ROIC64.8%59.9%-79.8%125.1%62.7%19.8%169.8%---
Return on Invested Capital (ROIC) TTM          
ROIC TTM29.4%37.7%47.1%155.9%69.9%52.9%105.5%---

Price Behavior

HIT Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta1.334.743.621.180.660.42
Up Beta2.6211.044.981.090.91-0.52
Down Beta-1.393.561.010.99-0.03-0.36
Up Capture262%464%1170%497%1%0%
Bmk +ve Days13233574144420
Stock +ve Days10203667103103
Down Capture-28%72%-126%4%67%42%
Bmk -ve Days8192952107330
Stock -ve Days112126568484

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity133,534
Short Interest: % Change Since 9302025-13.3%
Average Daily Volume412,145
Days-to-Cover Short Interest1
Basic Shares Quantity55,382,395
Short % of Basic Shares0.2%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/21/202525.2%21.5%137.8%
3/17/2025-18.2%-22.8%-15.6%
SUMMARY STATS   
# Positive111
# Negative111
Median Positive25.2%21.5%137.8%
Median Negative-18.2%-22.8%-15.6%
Max Positive25.2%21.5%137.8%
Max Negative-18.2%-22.8%-15.6%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025808202510-Q 6/30/2025
3312025509202510-Q 3/31/2025
12312024317202510-K 12/31/2024
63020248302024S-1 6/30/2024
33120246272024DRS/A 3/31/2024
1231202312232024424B4 12/31/2023

Insider Activity

Expand for More

 

External Quote Links


Prefer one of these to Trefis? Tell us why.